THU0127 IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM 5-YEAR FOLLOW UPД. В. Буханова, M. Cherkasova, Н. В. Демидова et al.|Annals of the Rheumatic Diseases|2019Cited by 9
INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSГ. М. Тарасова, Т. В. Попкова, Т. М. Reshetnyak et al.|Rheumatology Science and Practice|2018Cited by 7
FRI0212 USE OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP OF IMMUNOGENICITY WITH THERAPYGalina Tarasova, Т. В. Попкова, Б. С. Белов et al.|Annals of the Rheumatic Diseases|2019Cited by 7